GOVX GeoVax Labs, Inc.

$0.46▼ -0.54% Healthcare Other
After hours $0.46▼ -1.73% Sep 11, 7:46 PM ET
Volume 124.2K Avg Volume (10D) 803.0K
Key Metrics & Fundamentals
Market Cap
$4.21M
P/E Ratio
–
Div Yield
–%
52W Range
0.45 - 18.00
% vs 50 MA
-40.35%
% vs 200 MA
-80.68%
RSI-14
28.8
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.83
Free Cash Flow
-$3.66M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$4.43M
COGS
–
Operating Exp
$4.44M
Operating Income
-$4.44M
EBIT
-$4.44M
Pretax Income
-$4.43M
Net Income
-$4.43M
EPS (Diluted)
-0.97
Price & Volume History
Loading chart…
Recent News
GeoVax Provides Nasdaq Listing Update and Reaffirms Focus on Advancing Strategic Priorities
NewMediaWire · Sep 10, 2026 12:37 PM
GeoVax Welcomes Launch of Global Mpox Vaccine Stockpile, Highlights GEO-MVA Readiness to Support Diversified Global Supply
NewMediaWire · Sep 9, 2026 1:00 PM
GeoVax Announces a Warrant Inducement Transaction
NewMediaWire · Aug 26, 2026 12:30 PM
GeoVax Advances GEO-MVA Toward Pivotal Phase 3 Study Implementation
NewMediaWire · Aug 25, 2026 12:37 PM
GeoVax Initiates Global Health Outreach to WHO, Africa CDC and Other Agencies Regarding Ebola Vaccine Portfolio Amid Expanding Outbreak
NewMediaWire · Aug 24, 2026 2:43 PM
GeoVax Applauds Clinical Validation of Combination Immunotherapy Strategies
NewMediaWire · Aug 24, 2026 12:37 PM
GeoVax Chairman and CEO David Dodd to Participate in 2026 Georgia Life Sciences Summit
NewMediaWire · Aug 20, 2026 1:00 PM
GeoVax Highlights Capabilities Amid Congo's Expanding Ebola Outbreak
NewMediaWire · Aug 13, 2026 3:00 PM
GeoVax Highlights Gedeptin(R) Tumor-Priming Strategy as Immuno-Oncology Enters New Phase
NewMediaWire · Aug 11, 2026 1:00 PM
GeoVax targets Q4 phase 3 trial for MVA mpox vaccine with EMA expedited pathway
Proactive · Aug 10, 2026 9:02 PM
Financial Overview - Income Statement Quarterly

See GOVX's money flow as a full page

Social Sentiment
Avg +0.60 · 4 posts
DiscussionTradeDDNot sure if this is the best place but have a question on an IPO w/ warrants a company issued
r/investing · Jul 11, 2025
The author expresses optimism about the company's upside potential and owns shares, indicating a positive sentiment.
positive +0.60
Share my view and watchlist on mpox(monkeypox) investment. ( Not PennyStock )
r/stocks · Aug 26, 2024
The post highlights GOVX's license agreement with NIAID, indicating potential upside for the stock due to the expanding Mpox vaccine development.
positive +0.60
Share my view and watchlist on mpox(monkeypox) investment. ( Not PennyStock )
r/stocks · Aug 26, 2024
The post highlights GOVX's license agreement with NIAID, indicating potential upside for the stock.
positive +0.60
NewsDiscussionTradeIs anyone else getting greedy about GOVX
r/investing · Aug 22, 2024
The author expresses cautious optimism about GOVX, citing CEO holdings, monkeypox potential, and vaccine trials. Despite some concerns, the overall sentiment leans positive.
positive +0.60
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙